November 27, 2023
(press release)
–
Nestlé has launched its first product with HMOs in
Key Highlights: * Nestlé's R&D for Nutrition has been studying the composition of human breast milk for over 30 years. * Nestlé plans to expand its HMO offering in
Original Press Release:
Nestlé announces the launch of its science-based growing-up milk solution containing HMOs (Human Milk Oligosaccharides) for early life nutrition in mainland
The launch of this illuma growing-up milk builds on Nestlé's global leadership in HMO science across its entire formula brand portfolio. It was the first company to introduce a complex of five HMOs in products, globally. Last month, for example, the company introduced Sinergity, its latest proprietary blend that combines a specific probiotic with six age-adapted human milk oligosaccharides (HMOs) to support infant development by unlocking specific health benefits. Sinergity was rolled out first in
[Category: New Offerings] Source: Nestlé
This follows the recent approval for the use of such bioactives by the country's
HMOs are the third most abundant solid component in human breast milk, after lactose and lipids. Human breast milk contains three major types of these structurally complex carbohydrates. The illuma product launched this month contains 2'Fucosyllactose (2'FL) and Lacto-N-(neo)tetraose (LNnT), which account for two of the three major types of HMOs . The illuma blend additionally contains healthy lipids and proteins that together with the HMOs , also play a role in gut and immune health and cognitive development.
Manufactured at the Nestlé factory in
Nestlé is a pioneer in Human Milk Oligosaccharides (HMO) science and has conducted a significant number of HMO -related clinical studies and filed many patents related to HMOs . The scientific research takes place at the company's global R&D organization, in collaboration with an extensive network of academic research centers and universities worldwide.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.